Download PDF
Semin Thromb Hemost 2025; 51(02): 155-169
DOI: 10.1055/s-0044-1796673
Review Article

Factor XIII Deficiency: Laboratory, Molecular, and Clinical Aspects

Akbar Dorgalaleh
1   Hamin Pazhuhan Tis Institute, Tehran, Iran
,
Sina Jozdani
2   Department of Hematology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
,
Masoumeh Kiani Zadeh
3   Department of Hematology, High Institute for Education and Research in Transfusion Medicine, Tehran, Iran
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Factor XIII-A (FXIII-A) deficiency is an ultra-rare bleeding disorder characterized by high rates of morbidity and mortality, primarily resulting from intracranial hemorrhage, umbilical cord bleeding, and miscarriage, whereas patients with severe FXIII-B deficiency present with a milder phenotype. Although the estimated incidence of severe FXIII-A deficiency is one per 2 million, a high prevalence ranging from 0.8 to 3.5% has been observed for heterozygous FXIII-A deficiency. Unlike most bleeding disorders, individuals with heterozygous FXIII-A deficiency, particularly women, are more likely to experience hemorrhagic complications during hemostatic challenges. About 200 Mutations have been observed in F13A and F13B genes, with most being missense mutations, while large deletions are the rarest. There is no correlation between genotype and phenotype and a moderate to strong correlation between factor activity and clinical severity in FXIII-A deficiency, making it difficult to predict bleeding patterns based on genotype and FXIII activity levels. Primary prophylaxis is mandatory for all patients with severe FXIII-A deficiency, while those with heterozygous deficiency are generally asymptomatic and may require on-demand therapy during hemostatic challenges, most commonly in women. On the other hand, patients with severe FXIII-B deficiency may only require on-demand therapy, while heterozygotes are generally asymptomatic. Although there are general recommended therapeutic regimens for prophylaxis or on-demand therapy in different situations, personalized pharmacokinetic-based replacement therapy represents the optimal approach that can optimize intervention efficacy. In such an approach, several factors may affect the effectiveness of treatment and determine the dose and type of intervention, including the classification of FXIII deficiency, residual plasma levels of FXIII, clinical situation requiring intervention, age, weight, and also gender.

Keywords

FXIII deficiency - rare bleeding disorders - intracranial hemorrhage - umbilical cord bleeding


Publication History

Article published online:
29 November 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Dorgalaleh A, Rashidpanah J. Blood coagulation factor XIII and factor XIII deficiency. Blood Rev 2016; 30 (06) 461-475
    CrossrefPubMedSearch in Google Scholar
  • 2 Dorgalaleh A, Tabibian S, Shams M. et al. A unique factor XIII mutation in southeastern Iran with an unexpectedly high prevalence: Khash factor XIII. Semin Thromb Hemost 2019; 45 (01) 43-49
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 World Federation of Hemophilia.. World Federation of Hemophilia Report on the Annual Global Survey 2022. 2022. . Accessed November 11, 2024 at: https://www1.wfh.org/publications/files/pdf-2399.pdf
    Search in Google Scholar
  • 4 Singh S, Pezeshkpoor B, Jamil MA. et al. Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency. J Thromb Haemost 2024; 22 (02) 379-393
    CrossrefPubMedSearch in Google Scholar
  • 5 Kohler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L. Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 9 (07) 1404-1406
    CrossrefPubMedSearch in Google Scholar
  • 6 Muszbek L, Katona É. Diagnosis and management of congenital and acquired FXIII deficiencies. Semin Thromb Hemost 2016; 42 (04) 429-439
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Naderi M, Dorgalaleh A, Alizadeh S. et al. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol 2014; 100 (05) 443-449
    CrossrefPubMedSearch in Google Scholar
  • 8 Dorgalaleh A. Novel insights into heterozygous factor XIII deficiency. Semin Thromb Hemost 2024; 50 (02) 200-212
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol 2012; 95 (04) 362-370
    CrossrefPubMedSearch in Google Scholar
  • 10 Ivaskevicius V, Biswas A, Loreth R. et al. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 2010; 16 (04) 675-682
    CrossrefPubMedSearch in Google Scholar
  • 11 Jennings I, Kitchen S, Menegatti M. et al. Detection of factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories. Int J Lab Hematol 2017; 39 (04) 350-358
    CrossrefPubMedSearch in Google Scholar
  • 12 Dorgalaleh A. The history of factor XIII deficiency. Seminars in Thrombosis and Hemostasis 2024; 50 (01) 034-042
    Thieme ConnectPubMedSearch in Google Scholar
  • 13 Asahina T, Kobayashi T, Okada Y, Goto J, Terao T. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000; 21 (04) 388-393
    CrossrefPubMedSearch in Google Scholar
  • 14 Inbal A, Lubetsky A, Krapp T. et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 2005; 94 (02) 432-437
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Dardik R, Solomon A, Loscalzo J. et al. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol 2003; 23 (08) 1472-1477
    CrossrefPubMedSearch in Google Scholar
  • 16 Fadoo Z, Merchant Q, Rehman KA. New developments in the management of congenital factor XIII deficiency. J Blood Med 2013; 4 (04) 65-73
    CrossrefPubMedSearch in Google Scholar
  • 17 Komáromi I, Bagoly Z, Muszbek L. Factor XIII: novel structural and functional aspects. J Thromb Haemost 2011; 9 (01) 9-20
    CrossrefPubMedSearch in Google Scholar
  • 18 Vasilyeva A, Yurina L, Shchegolikhin A. et al. The structure of blood coagulation factor XIII is adapted to oxidation. Biomolecules 2020; 10 (06) 914
    CrossrefPubMedSearch in Google Scholar
  • 19 Singh S, Nazabal A, Kaniyappan S. et al. The plasma factor XIII heterotetrameric complex structure: unexpected unequal pairing within a symmetric complex. Biomolecules 2019; 9 (12) 765
    CrossrefPubMedSearch in Google Scholar
  • 20 Souri M, Biswas A, Misawa M, Omura H, Ichinose A. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines. Haemophilia 2014; 20 (02) 255-262
    CrossrefPubMedSearch in Google Scholar
  • 21 Maeda S, Zhang WG, Souri M, Yee VC, Ichinose A. Impaired dimer assembly and decreased stability of naturally recurring R260C mutant A subunit for coagulation factor XIII. J Biochem 2012; 152 (05) 471-478
    CrossrefPubMedSearch in Google Scholar
  • 22 Ivaskevicius V, Biswas A, Bevans C. et al. Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 2010; 95 (06) 956-962
    CrossrefPubMedSearch in Google Scholar
  • 23 Dorgalaleh A, Bahraini M, Shams M. et al. Molecular basis of rare congenital bleeding disorders. Blood Rev 2023; 59: 101029
    CrossrefPubMedSearch in Google Scholar
  • 24 Souri M, Yee VC, Fujii N, Ichinose A. Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency. Thromb Res 2012; 130 (03) 506-510
    CrossrefPubMedSearch in Google Scholar
  • 25 Mikkola H, Yee VC, Syrjälä M. et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 1996; 87 (01) 141-151
    CrossrefPubMedSearch in Google Scholar
  • 26 Javed H, Singh S, Ramaraje Urs SU, Oldenburg J, Biswas A. Genetic landscape in coagulation factor XIII associated defects - advances in coagulation and beyond. Blood Rev 2023; 59: 101032
    CrossrefPubMedSearch in Google Scholar
  • 27 Vysokovsky A, Saxena R, Landau M. et al. Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. J Thromb Haemost 2004; 2 (10) 1790-1797
    CrossrefPubMedSearch in Google Scholar
  • 28 Deng J, Li D, Mei H, Tang L, Wang HF, Hu Y. Novel deep intronic mutation in the coagulation factor XIII a chain gene leading to unexpected RNA splicing in a patient with factor XIII deficiency. BMC Med Genet 2020; 21 (01) 9
    CrossrefPubMedSearch in Google Scholar
  • 29 Anwar R, Miloszewski KJ, Markham AF. Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family. Blood 1998; 91 (01) 149-153
    CrossrefPubMedSearch in Google Scholar
  • 30 Otaki M, Inaba H, Shinozawa K, Fujita S, Amano K, Fukutake K. Characterization of a large deletion that leads to congenital factor XIII deficiency [in Japanese]. Rinsho Byori 2008; 56 (03) 187-194
    PubMedSearch in Google Scholar
  • 31 Ivaskevicius V, Windyga J, Baran B. et al. Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia 2007; 13 (05) 649-657
    CrossrefPubMedSearch in Google Scholar
  • 32 Cai R, Li Y, Wang W, Feng Q. A novel Cys328-terminator mutant implicated in severe coagulation factor XIII deficiency: a case report. BMC Med Genet 2020; 21 (01) 175
    CrossrefPubMedSearch in Google Scholar
  • 33 Singh S, Akhter MS, Dodt J. et al. Disruption of structural disulfides of coagulation FXIII-B subunit; functional implications for a rare bleeding disorder. Int J Mol Sci 2019; 20 (08) 1956
    CrossrefPubMedSearch in Google Scholar
  • 34 Duan B, Wang X, Chu H. et al. Deficiency of factor XIII gene in Chinese: 3 novel mutations. Int J Hematol 2003; 78 (03) 251-255
    CrossrefPubMedSearch in Google Scholar
  • 35 Borhany M, Handrkova H, Cairo A. et al. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations. Haemophilia 2014; 20 (04) 568-574
    CrossrefPubMedSearch in Google Scholar
  • 36 Shanbhag S, Ghosh K, Shetty S. Genetic basis of severe factor XIII deficiency in a large cohort of Indian patients: Identification of fourteen novel mutations. Blood Cells Mol Dis 2016; 57 (06) 81-84
    CrossrefPubMedSearch in Google Scholar
  • 37 Naderi M, Reykande SE, Dorgalaleh A. et al. Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran. Blood Coagul Fibrinolysis 2016; 27 (01) 97-100
    CrossrefPubMedSearch in Google Scholar
  • 38 Daneshi M, Dorgalaleh A, Tabibian S, Safa M, Naderi M, Kazemi A. Premarital screening program for congenital factor XIII deficiency in Iran. Clin Lab 2020; 66 (08) 1495
    PubMedSearch in Google Scholar
  • 39 Dorgalaleh A, Naderi M, Hosseini MS. et al. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost 2015; 41 (03) 323-329
    Thieme ConnectPubMedSearch in Google Scholar
  • 40 Louhichi N, Medhaffar M, Hadjsalem I. et al. Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect. Ann Hematol 2010; 89 (05) 499-504
    CrossrefPubMedSearch in Google Scholar
  • 41 Inbal A, Yee VC, Kornbrot N, Zivelin A, Brenner B, Seligsohn U. Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families. Thromb Haemost 1997; 77 (06) 1062-1067
    Thieme ConnectPubMedSearch in Google Scholar
  • 42 Ivaskevicius V, Seitz R, Kohler HP. et al; Study Group. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97 (06) 914-921
    Thieme ConnectPubMedSearch in Google Scholar
  • 43 Jang M-A, Park YS, Lee K-O, Kim H-J. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency. Blood Coagul Fibrinolysis 2015; 26 (01) 46-49
    CrossrefPubMedSearch in Google Scholar
  • 44 Ichinose A, Osaki T, Souri M. Autoimmune acquired factor XIII deficiency in Japan 2021 update: focused on annual incidence and clinical features. Haemophilia 2022; 28 (05) e121-e124
    CrossrefPubMedSearch in Google Scholar
  • 45 Dorgalaleh A, Naderi M, Shamsizadeh M. Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency. Ann Hematol 2016; 95 (03) 451-455
    CrossrefPubMedSearch in Google Scholar
  • 46 Dorgalaleh A, Daneshi M, Dabbagh A, Crookston KP. Congenital bleeding disorders: diagnosis and management. In: Congenital Bleeding Disorders: Diagnosis and Management. Cham:: Springer International Publishing;; 2023: 29-74
    CrossrefSearch in Google Scholar
  • 47 Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding–a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics 2002; 109 (02) E32
    CrossrefPubMedSearch in Google Scholar
  • 48 Casini A, von Mackensen S, Santoro C. et al; QualyAfib Study Group. Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia. Blood 2021; 137 (22) 3127-3136
    CrossrefPubMedSearch in Google Scholar
  • 49 Duckert F. The fibrin stabilizing factor, factor XIII. Blut 1973; 26 (03) 177-179
    CrossrefPubMedSearch in Google Scholar
  • 50 Shetty S, Shelar T, Mirgal D. et al. Rare coagulation factor deficiencies: a countrywide screening data from India. Haemophilia 2014; 20 (04) 575-581
    CrossrefPubMedSearch in Google Scholar
  • 51 Alavi SER, Jalalvand M, Assadollahi V, Tabibian S, Dorgalaleh A. Intracranial hemorrhage: a devastating outcome of congenital bleeding disorders-prevalence, diagnosis, and management, with a special focus on congenital factor XIII deficiency. Semin Thromb Hemost 2018; 44 (03) 267-275
    Thieme ConnectPubMedSearch in Google Scholar
  • 52 Tabibian S, Shams M, Naderi M, Dorgalaleh A. Prenatal diagnosis in rare bleeding disorders-an unresolved issue?. Int J Lab Hematol 2018; 40 (03) 241-250
    CrossrefPubMedSearch in Google Scholar
  • 53 Singleton TC, Keane M. Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: a case report and review. Ochsner J 2012; 12 (03) 249-253
    PubMedSearch in Google Scholar
  • 54 Sharief LA, Kadir RA. Congenital factor XIII deficiency in women: a systematic review of literature. Haemophilia 2013; 19 (06) e349-e357
    CrossrefPubMedSearch in Google Scholar
  • 55 Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 2003; 29 (02) 171-174
    Thieme ConnectPubMedSearch in Google Scholar
  • 56 Nahrendorf M, Hu K, Frantz S. et al. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation 2006; 113 (09) 1196-1202
    CrossrefPubMedSearch in Google Scholar
  • 57 D'Argenio G, Grossman A, Cosenza V, Valle ND, Mazzacca G, Bishop PD. Recombinant factor XIII improves established experimental colitis in rats. Dig Dis Sci 2000; 45 (05) 987-997
    CrossrefPubMedSearch in Google Scholar
  • 58 Alshehri FSM, Whyte CS, Mutch NJ. Factor XIII-A: an indispensable “factor” in haemostasis and wound healing. Int J Mol Sci 2021; 22 (06) 3055
    CrossrefPubMedSearch in Google Scholar
  • 59 Karaman S, Akkaya E, Genc S. et al. Congenital factor XIII deficiency with the presence of inhibitor: a case study. J Pediatr Hematol Oncol 2021; 43 (01) e99-e102
    CrossrefPubMedSearch in Google Scholar
  • 60 Girolami A, Burul A, Sticchi A. Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family. Acta Haematol 1977; 58 (01) 17-26
    CrossrefPubMedSearch in Google Scholar
  • 61 Izumi T, Hashiguchi T, Castaman G. et al. Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. Blood 1996; 87 (07) 2769-2774
    CrossrefPubMedSearch in Google Scholar
  • 62 Koseki S, Souri M, Koga S. et al. Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood 2001; 97 (09) 2667-2672
    CrossrefPubMedSearch in Google Scholar
  • 63 Souri M, Izumi T, Higashi Y, Girolami A, Ichinose A. A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second Sushi domain. Thromb Haemost 1998; 80 (02) 211-213
    Thieme ConnectPubMedSearch in Google Scholar
  • 64 Hashiguchi T, Saito M, Morishita E, Matsuda T, Ichinose A. Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. Blood 1993; 82 (01) 145-150
    CrossrefPubMedSearch in Google Scholar
  • 65 Egbring R, Seitz R, Gürten GV. et al. Bleeding complications in heterozygotes with congenital factor XIII deficiency. In: Mosesson MW, Amrani DL, Siebenlist KR, DiOrio JP. eds. Fibrinogen 3: Biochemistry, Biological Functions, Gene Regulation, and Expression. 1988: 341-346
    Search in Google Scholar
  • 66 Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U. Study Group. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Semin Thromb Hemost 1996; 22 (05) 415-418
    Thieme ConnectPubMedSearch in Google Scholar
  • 67 Egbring R, Rohner I, Lerch L, Fuchs G, Kröniger A, Seitz R. Bleeding complications in patients with heterozygous FXIII subunit A deficiency?. Blood Coagul Fibrinolysis 1995; 6: 340
    PubMedSearch in Google Scholar
  • 68 Mahmoodi M, Peyvandi F, Afrasiabi A, Ghaffarpasand F, Karimi M. Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis 2011; 22 (05) 396-401
    CrossrefPubMedSearch in Google Scholar
  • 69 Dorgalaleh A, Tabibian S, Hosseini MS. et al. Diagnosis of factor XIII deficiency. Hematology 2016; 21 (07) 430-439
    CrossrefPubMedSearch in Google Scholar
  • 70 Dorgalaleh A, Tabibian S, Assadollahi V. et al. Comparison of 2 methods of clot solubility testing in detection of factor XIII deficiency. Lab Med 2016; 47 (04) 283-285
    CrossrefPubMedSearch in Google Scholar
  • 71 Durda MA, Wolberg AS, Kerlin BA. State of the art in factor XIII laboratory assessment. Transfus Apher Sci 2018; 57 (06) 700-704
    CrossrefPubMedSearch in Google Scholar
  • 72 Lee IH, Chung SI, Lee SY. Effects of Val34Leu and Val35Leu polymorphism on the enzyme activity of the coagulation factor XIII-A. Exp Mol Med 2002; 34 (05) 385-390
    CrossrefPubMedSearch in Google Scholar
  • 73 Wilmer M, Rudin K, Kolde H. et al. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Thromb Res 2001; 102 (01) 81-91
    CrossrefPubMedSearch in Google Scholar
  • 74 Parameswaran KN, Cheng XF, Chen EC, Velasco PT, Wilson JH, Lorand L. Hydrolysis of gamma:epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem 1997; 272 (15) 10311-10317
    CrossrefPubMedSearch in Google Scholar
  • 75 Oertel K, Hunfeld A, Specker E. et al. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem 2007; 367 (02) 152-158
    CrossrefPubMedSearch in Google Scholar
  • 76 Czembirek C, Poeschl WP, Eder-Czembirek C. et al. Causes and timing of delayed bleeding after oral surgery. Clin Oral Investig 2014; 18 (06) 1655-1661
    CrossrefPubMedSearch in Google Scholar
  • 77 Naderi M, Tabibian S, Menegatti M. et al. Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran. Blood Coagul Fibrinolysis 2016; 27 (08) 933-935
    CrossrefPubMedSearch in Google Scholar
  • 78 Dorgalaleh A, Tabibian S, Hosseini MS, Shams M. Pharmacological management of rare coagulation factor deficiencies besides hemophilia. Expert Rev Hematol 2020; 13 (08) 811-834
    CrossrefPubMedSearch in Google Scholar
  • 79 Peyvandi F, Palla R, Menegatti M. et al; European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10 (04) 615-621
    CrossrefPubMedSearch in Google Scholar
  • 80 Menegatti M, Palla R, Boscarino M. et al; PRO-RBDD study group. Minimal factor XIII activity level to prevent major spontaneous bleeds. J Thromb Haemost 2017; 15 (09) 1728-1736
    CrossrefPubMedSearch in Google Scholar
  • 81 Sarmiento Doncel S, Diaz Mosquera GA, Cortes JM, Ramirez Plazas N, Meza FJ, Agudelo Rico C. Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program. Hematol Rep 2021; 13 (04) 8904
    CrossrefPubMedSearch in Google Scholar
  • 82 Dorgalaleh A, Tabibian SH, Safa M, Shams M, Naderi M. Minimal factor XIII activity level to prevent major spontaneous bleeds: comment. J Thromb Haemost 2017; 15 (11) 2279-2280
    CrossrefPubMedSearch in Google Scholar
  • 83 Mumford AD, Ackroyd S, Alikhan R. et al; BCSH Committee. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014; 167 (03) 304-326
    CrossrefPubMedSearch in Google Scholar
  • 84 Pasca S, PierGiorgio C, Pea F. Ezio Zanon; the Italian rFXIII Study Group. The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTOR™2 trial to a real-world study: a head-to-head comparison. J Thromb Thrombolysis 2022; 54 (04) 593-596
    CrossrefPubMedSearch in Google Scholar
  • 85 Kerlin B, Brand B, Inbal A. et al. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. J Thromb Haemost 2014; 12 (12) 2038-2043
    CrossrefPubMedSearch in Google Scholar
  • 86 Nugent D. Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study. Thromb Res 2012; 130 (13, Suppl 2): S12-S14
    CrossrefPubMedSearch in Google Scholar
  • 87 Suzuki H, Kaneda T. Tooth extraction in two patients who had a congenital deficiency of factor XIII. J Oral Maxillofac Surg 1985; 43 (03) 221-224
    CrossrefPubMedSearch in Google Scholar
  • 88 Janbain M, Nugent DJ, Powell JS, St-Louis J, Frame VB, Leissinger CA. Use of factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures. Transfusion 2015; 55 (01) 45-50
    CrossrefPubMedSearch in Google Scholar
  • 89 Carcao M, Altisent C, Castaman G. et al. Recombinant FXIII (rFXIII-A2) prophylaxis prevents bleeding and allows for surgery in patients with congenital FXIII A-subunit deficiency. Thromb Haemost 2018; 118 (03) 451-460
    Thieme ConnectPubMedSearch in Google Scholar
  • 90 Haslinger C, Korte W, Hothorn T, Brun R, Greenberg C, Zimmermann R. The impact of prepartum factor XIII activity on postpartum blood loss. J Thromb Haemost 2020; 18 (06) 1310-1319
    CrossrefPubMedSearch in Google Scholar
  • 91 Bamberg C, Mickley L, Henkelmann A. et al. The impact of antenatal factor XIII levels on postpartum haemorrhage: a prospective observational study. Arch Gynecol Obstet 2019; 299 (02) 421-430
    CrossrefPubMedSearch in Google Scholar
  • 92 Ribizzi G, Farinini D, Gentile R, Rizzi D, Serrati C. Factor XIII deficiency and head trauma: management and therapy. Neurol Sci 2015; 36 (10) 1933-1934
    CrossrefPubMedSearch in Google Scholar
  • 93 Naderi M, Alizadeh S, Kazemi A. et al. Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases. Hematology 2015; 20 (02) 112-118
    CrossrefPubMedSearch in Google Scholar
  • 94 Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003; 1 (08) 1852-1853
    CrossrefPubMedSearch in Google Scholar
  • 95 Saito M, Asakura H, Yoshida T. et al. A familial factor XIII subunit B deficiency. Br J Haematol 1990; 74 (03) 290-294
    CrossrefPubMedSearch in Google Scholar
  • 96 Capellato MG, Lazzaro AR, Marafioti F, Polato G, Girolami A. A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency. Haematologia (Budap) 1987; 20 (03) 179-187
    PubMedSearch in Google Scholar